Signatur Biosciences raises €6.3M Seed round
22 May 2025· London, United Kingdom· health, biotechnology, molecular_diagnostics, diagnostic_testing, software_hardware, b2b
The funding will be used to finalise and validate OncoSignatur Breast, unlock and match public grants for product development, establish a dedicated laboratory in Liège, Belgium, and expand its scientific and operational team to support R&D and commercialisation. It will also be used to expand research and development efforts, further refine testing processes, and broaden global reach.
Investors
LeadThe Discovery Lab of IBA
Also participating
Anjost InvestmentNoshaqMyelin VCPSR CryptoRiceberg Ventures
About Signatur Biosciences
Stage
Seed
Headquarters
London, United Kingdom
Founded
2022
Team Size
6–20
Sectors
healthbiotechnologymolecular_diagnosticsdiagnostic_testingsoftware_hardwareb2b